Professor Vijay Kunadian
Helen Mossop
Carol Shields
Philippa Watts
Professor Dawn Teare
et al. | Invasive Treatment Strategy for Older Patients with Myocardial Infarction | 2024 |
|
Alastair Gray
Dr Mark De Belder
Professor Steve Jones
Christopher Malkin
Dr Andrew Owens
et al. | Effect of Transcatheter Aortic Valve Implantation vs Surgical Aortic Valve Replacement on All-Cause Mortality in Patients With Aortic Stenosis: A Randomized Clinical Trial | 2022 |
|
Dr Mark De Belder
Professor Azfar Zaman
| Survival relative to pacemaker status after transcatheter aortic valve implantation | 2021 |
|
Professor Azfar Zaman
Dr Mark De Belder
| Transcatheter aortic valve implantation via surgical subclavian versus direct aortic access: A United Kingdom analysis | 2020 |
|
Professor Azfar Zaman
Dr Mohaned Egred
Professor Thomas Johnson
Dr Mark De Belder
| Acute and one-year clinical outcomes following implantation of bioresorbable vascular scaffolds: The ABSORB UK Registry | 2018 |
|
Dr Matthew Jackson
Dr David Austin
Muhammad Rashid
Dr Mark De Belder
Professor Azfar Zaman
et al. | The impact of diabetes on the prognostic value of left ventricular function following percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society | 2018 |
|
Dr Mark De Belder
Professor Azfar Zaman
| Choice of Stent for Percutaneous Coronary Intervention of Saphenous Vein Grafts | 2017 |
|
Dr Mark De Belder
Professor Azfar Zaman
| The Relationship of Body Mass Index to Percutaneous Coronary Intervention Outcomes: Does the Obesity Paradox Exist in Contemporary Percutaneous Coronary Intervention Cohorts? Insights From the British Cardiovascular Intervention Society Registry | 2017 |
|
Dr Mark De Belder
Professor Azfar Zaman
| Changes in Arterial Access Site and Association With Mortality in the United Kingdom: Observations From a National Percutaneous Coronary Intervention Database | 2016 |
|
Dr Mark De Belder
Professor Azfar Zaman
| Outcomes Following Primary Percutaneous Coronary Intervention in Patients With Previous Coronary Artery Bypass Surgery | 2016 |
|
Dr Andrew Turley
Dr James Hall
Dr Neil Swanson
Professor Rudy Bilous
Dr Mark De Belder
et al. | The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary intervention | 2016 |
|
Professor Vijay Kunadian
Professor Azfar Zaman
Dr Mark De Belder
| Effect of access site, gender, and indication on clinical outcomes after percutaneous coronary intervention: Insights from the British Cardiovascular Intervention Society (BCIS) | 2015 |
|
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
| Impact of age on access site-related outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the British Cardiovascular Intervention Society | 2015 |
|
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
| Impact of Age on the Prognostic Value of Left Ventricular Function in Relation to Procedural Outcomes Following Percutaneous Coronary Intervention: Insights From the British Cardiovascular Intervention Society | 2015 |
|
Professor Azfar Zaman
Professor Bernard Keavney
Dr Mark De Belder
| Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12 | 2015 |
|
Professor Bernard Keavney
Professor Azfar Zaman
Dr Mark De Belder
| Impact of left ventricular function in relation to procedural outcomes following percutaneous coronary intervention: insights from the British Cardiovascular Intervention Society | 2014 |
|
Professor Gerard Stansby
Dr Mark De Belder
Professor John Dark
Professor Gary Ford
| Asymptomatic carotid disease and cardiac surgery consensus | 2011 |
|
Professor Vijay Kunadian
Dr Neil Swanson
Dr Mark De Belder
| Percutaneous coronary intervention using radial access is associated with less radiation exposure to patients compared with femoral access | 2011 |
|
Professor Vijay Kunadian
Claire Chapple
Dr James Hall
Dr Mark De Belder
| Cardiac catheterisation: radiation doses and lifetime risk of malignancy | 2007 |
|
Professor Vijay Kunadian
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Professor Jeremy Murphy
et al. | Early invasive versus conservative treatment in patients with failed fibrinolysis-no late survival benefit: The final analysis of the Middlesbrough Early Revascularisation to Limit Infarction (MERLIN) randomized trial | 2007 |
|
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Professor Jeremy Murphy
Dr Ananthaiah Shyam-Sundar
et al. | One year results of the Middlesbrough early revascularisation to limit infarction (MERLIN) trial | 2005 |
|
Dr Philip Campbell
Dr Janine Gray
Dr James Hall
Dr Alun Harcombe
Amy Wright
et al. | A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: The Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial | 2004 |
|
Jean Gray
Dr Alun Harcombe
Dr James Hall
Dr Mark De Belder
| The Middlesbrough early revascularisation to limit INfarction (MERLIN) trial: A randomised trial of rescue angioplasty versus medical treatment for failed fibrinolyis | 2003 |
|
Dr James Hall
Dr Alun Harcombe
Dr Mark De Belder
| Thrombocytopenia after abciximab use during percutaneous coronary intervention | 2003 |
|
Dr Janet McComb
Dr Mark De Belder
| Erosion of the left ventricle by the epicardial patch of an automatic implantable cardioverter defibrillator | 1999 |
|
